Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Medipharm Labs Corp.

Start price
Target price
Perf. (%)
€0.53
08.02.21
€1.90
08.02.22
-57.53%
12.10.21

yedi2332 
08.02.21 50%
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€56.80
08.02.21
€70.00
08.02.22
6.16%
09.02.22

Konrad 
08.02.21 50%
buy
Onconova Therapeutics Inc

Start price
Target price
Perf. (%)
€11.84
08.02.21
€105.00
08.02.22
-73.81%
12.10.21

yedi2332 
08.02.21 89%
buy
VIVO Cannabis Inc.

Start price
Target price
Perf. (%)
€0.17
08.02.21
€1.00
08.02.22
-55.85%
12.10.21

yedi2332 
08.02.21 90%
buy
Aim Immunotech Inc.

Start price
Target price
Perf. (%)
€2.30
08.02.21
€8.00
08.02.22
-28.04%
12.10.21

yedi2332 
08.02.21 89%
buy
PostNL N.V.

Start price
Target price
Perf. (%)
€3.49
08.02.21
€7.00
08.02.22
12.62%
12.10.21

yedi2332 
08.02.21 80%
buy
Gamestop Corp.

Start price
Target price
Perf. (%)
€14.50
08.02.21
-
08.02.22
-1.91%
08.02.21

Risky Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
Little Investments for future growth
Amped 
08.02.21 0%
buy
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€14.07
08.02.21
-
08.02.22
-1.54%
08.02.21

Could be very worthwhile Investment >20% year
Amped 
08.02.21 0%
buy
Novan Inc

Start price
Target price
Perf. (%)
€12.90
08.02.21
-
08.02.22
49.61%
15.02.21

Could be very worthwhile Investment >20% year
Amped 
08.02.21 0%
buy
Vislink Technologies Inc.

Start price
Target price
Perf. (%)
€77.20
08.02.21
-
08.02.22
2.07%
08.02.21

Could be very worthwhile Investment >20% year
Amped 
08.02.21 0%
buy
Ocugen Inc.

Start price
Target price
Perf. (%)
€7.56
08.02.21
-
08.02.22
-10.32%
08.02.21

Could be worthwhile Investment >10% per year
Amped 
08.02.21 0%
buy
Scryb Inc.

Start price
Target price
Perf. (%)
€0.58
08.02.21
€1.50
08.02.22
-72.76%
09.10.21

pille1910 
08.02.21 90%
buy
American States Water

Start price
Target price
Perf. (%)
€68.32
08.02.21
-
08.02.22
13.44%
07.08.21

Judge 
08.02.21 50%
sell
Netflix Inc.

Start price
Target price
Perf. (%)
€461.75
08.02.21
€165.00
08.02.22
16.86%
12.10.21

Volker 
08.02.21 60%
buy
Carbios S.A.

Start price
Target price
Perf. (%)
€55.30
08.02.21
-
18.01.25
-52.35%
12.01.24

Could be worthwhile Investment >10% per year
Gilbert 
08.02.21 0%
buy
AUTO1 Group SE

Start price
Target price
Perf. (%)
€50.10
08.02.21
€50.00
-8.54%
26.02.21

Could be worthwhile Investment >10% per year
Medium risks for its business
phonebroker 
08.02.21 50%
buy
alstria office REIT-AG

Start price
Target price
Perf. (%)
€14.10
08.02.21
-
08.02.22
37.38%
27.11.21

Commando 
08.02.21 50%
buy
Alphabet Inc. C

Start price
Target price
Perf. (%)
€87.48
08.02.21
-
08.02.22
45.20%
04.11.21

maz190671 
08.02.21 50%
buy
Nokia Corp.

Start price
Target price
Perf. (%)
€3.57
08.02.21
€5.00
-6.41%
22.02.21

Could be very worthwhile Investment >20% year
positive Cash Flow expected
Top Rating
Leading role in innovation
DomRuinart 
08.02.21 50%
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€3.44
08.02.21
€5.00
08.02.22
-27.31%
22.02.21

Could be worthwhile Investment >10% per year
DomRuinart 
08.02.21 50%
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.12
08.02.21
€5.00
08.02.22
14.10%
22.02.21

Could be worthwhile Investment >10% per year
DomRuinart 
08.02.21 50%
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€32.25
08.02.21
€50.00
08.02.22
6.98%
22.02.21

Could be worthwhile Investment >10% per year
DomRuinart 
08.02.21 50%
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€7.35
08.02.21
€9.00
08.02.22
-1.36%
22.02.21

Could be very worthwhile Investment >20% year
DomRuinart 
08.02.21 50%
buy
Overstock.com

Start price
Target price
Perf. (%)
€79.50
08.02.21
-
08.02.22
-13.48%
27.07.21

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
FXX 
08.02.21 50%
buy
eHealth Inc.

Start price
Target price
Perf. (%)
€48.35
08.02.21
-
08.02.22
16.56%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
FXX 
08.02.21 50%